Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR
Samantha Noteboom(Université de Bordeaux), Menno M. Schoonheim(Amsterdam Neuroscience), Bastiaan Moraal(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frederik Barkhof(Netherlands Institute for Neuroscience), Matthan W.A. Caan(Amsterdam University Medical Centers), Massimiliano Calabrese(University of Verona), Hugo Vrenken(Amsterdam Neuroscience), Martijn D. Steenwijk(Amsterdam Neuroscience), Albulena Bajrami(University of Verona), David R. van Nederpelt(Amsterdam Neuroscience), Eva Strijbis(Amsterdam University Medical Centers)
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k